Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436.

R. Clarke,H. W. van den Berg,D. Kennedy,R. Murphy
DOI: https://doi.org/10.1016/0277-5379(83)90391-7
European Journal of Cancer and Clinical Oncology
Abstract:
What problem does this paper attempt to address?